Company intelligence
Catalyst Pharmaceuticals, Inc.
We are committed to improving the lives of patients with rare diseases.
About Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. is a wholly owned subsidiary of Angelini Pharma. Catalyst is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence while actively seeking to expand its global commercial footprint through strategic partnerships. Catalyst is headquartered in Coral Gables, FL., and was recognized on the Forbes 2025 list as one of America's most successful small-cap companies. For more information, please visit Catalyst's website at www.catalystpharma.com. View our Privacy Policy: https://catalystpharma.com/privacy-policy/ View our Social Media Guidelines: https://catalystpharma.com/social-media-guidelines/
Verified activity
Signals from Catalyst Pharmaceuticals, Inc.
3 published signals
Presence & Recognition
Catalyst Pharmaceuticals, Inc. team members wore red StrongerThanDuchenne shirts from the Jett Foundation to support World Duchenne Awareness Day on September 7th.
Reported by Catalyst Pharmaceuticals, Inc.
People
Catalyst Pharmaceuticals, Inc. is hiring for Patient Advocacy in Duchenne muscular dystrophy and dedicated to supporting patients, caregivers, and advocacy organizations through meaningful, patient-centered initiatives.
Reported by Catalyst Pharmaceuticals, Inc.
Presence & Recognition
Catalyst Pharmaceuticals, Inc. hosted an episode of CatalystConvos featuring the story of Gaven and his motorcycle journey.
Reported by Catalyst Pharmaceuticals, Inc.